Patel, J. N., Jiang, C., Hertz, D. L., Mulkey, F. A., Owzar, K., Halabi, S., . . . McLeod, H. L. (2014). Bevacizumab and risk of arterial and venous thromboembolism in metastatic castration-resistant prostate cancer patients treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer.
Chicago Style CitationPatel, Jai N., et al. "Bevacizumab and Risk of Arterial and Venous Thromboembolism in Metastatic Castration-resistant Prostate Cancer Patients Treated On Cancer and Leukemia Group B (CALGB) 90401 (Alliance)." Cancer 2014.
MLA CitationPatel, Jai N., et al. "Bevacizumab and Risk of Arterial and Venous Thromboembolism in Metastatic Castration-resistant Prostate Cancer Patients Treated On Cancer and Leukemia Group B (CALGB) 90401 (Alliance)." Cancer 2014.